Register an account to search through 14,000+ stocks! 

Ad

VYNE – Vyne Therapeutics Inc

✔ COMPLIANT

★☆☆

Company Profile

Vyne Therapeutics Inc. is a specialty pharmaceutical company. The Company is engaged in developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions and rare skin diseases with high unmet medical need. The Company’s proprietary pipeline FMX114, which is a potential treatment of mild-to-moderate atopic dermatitis in patients 12 years of age and older, and access to a library of bromodomain and extra-terminal (BET) domain inhibitors in both topical and oral forms for the potential treatment of major immuno-inflammatory conditions and rare skin diseases.
Ad

Business

PASS

Vyne Therapeutics Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.

Impure: N/A

Recommendation Rating

2

1

2

3

4

5

Analysts’ Price Targets

Mean 5.8

Low: 6

High: 10

Total Analysts: 6

Financials

PASS

The financials pass just one standard and fail in the other two.

FTSE

Debt / Assets
35.39%
Cash / Assets
61.41%
(Cash + AR) / Assets
61.41%

AAOIFI

Debt / Market cap
100%
Non-Compliant Assets
0%

DJIM

Debt / 24MC
16.63%
Cash / 24MC
28.85%
AR / 24MC
0%

Fundamentals

Market cap

Assets

Revenue Growth

Div./Share

$30457044
$93742000

✘ FTSE

✘ AAOIFI

✔ DJIM

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses